N-succinimidyl 3-[211At]astato-4-guanidinomethylbenzoate: an acylation agent for labeling internalizing antibodies with α-particle emitting 211At
- 31 May 2003
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 30 (4), 351-359
- https://doi.org/10.1016/s0969-8051(03)00005-2
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Radioimmunotherapy for Acute LeukemiaCancer Control, 2002
- Evidence of high incidence of EGFRvIII expression and coexpression with EGFR in human invasive breast cancer by laser capture microdissection and immunohistochemical analysisInternational Journal of Cancer, 2002
- Therapeutic advantages of Auger electron- over β-emitting radiometals or radioiodine when conjugated to internalizing antibodiesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2000
- Synthesis, purification, and in vitro stability of 211At- and 125I-labeled amidobisphosphonatesNuclear Medicine and Biology, 1999
- Labeling of Monoclonal Antibodies with Diethylenetriaminepentaacetic Acid-Appended Radioiodinated Peptides Containingd-Amino AcidsBioconjugate Chemistry, 1999
- Evaluation of an internal cyclotron target for the production of 211At via the 209Bi (α,2n)211At reactionApplied Radiation and Isotopes, 1996
- Receptor blockade with monoclomal antibodies as anti-cancer therapyPharmacology & Therapeutics, 1994
- Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: A phase II trialInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails.Proceedings of the National Academy of Sciences, 1992
- Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excessJournal of Immunological Methods, 1984